|
Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
Am Heart J. 2004 Ago; 148(2):263-8.
Bhatt DL, Topol EJ; Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance Executive Committee |
|
Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.
Circulation. 2004 Jul; 110(2):214-9. Epub 2004 Jun 14
Esposito K, Giugliano D, Nappo F, Marfella R; Campanian Postprandial Hyperglycemia Study Group |
|
Cerebrovascular mortality 10 years after stroke: a population-based study.
Stroke. 2004 Jul; 35(7):343-5. Epub 2004 May 13
Terent A. |
|
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.
Circulation. 2004 Jun; 109(25):3171-5. Epub 2004 Jun 7
Matetzky S, Shenkman B, Guetta V, Shechter M, Bienart R, Goldenberg I, Novikov I, Pres H, Savion N, Varon D, Hod H. |
|
Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences.
Circulation. 2004 Jun; 109(24):3022-8. Epub 2004 Jun 7
Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Gallimore JR, Pepys MB, Campbell LV |
|
Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study.
Circulation. 2004 Jun; 109(23):2850-6. Epub 2004 Jun 1
Sundstrom J, Evans JC, Benjamin EJ, Levy D, Larson MG, Sawyer DB, Siwik DA, Colucci WS, Sutherland P, Wilson PW, Vasan RS |
|
Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial.
Circulation. 2004 Jun; 109(22):2727-31. Epub 2004 Jun 1
Singh M, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, Holmes DR Jr. |
|
Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies.
Circulation. 2004 Jun; 109(22):2705-11.
He K, Song Y, Daviglus ML, Liu K, Van Horn L, Dyer AR, Greenland P. |
|
Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.
Circulation. 2004 Jun; 109(22):2807-16.
Maron BJ, Chaitman BR, Ackerman MJ, Bayes de Luna A, Corrado D, Crosson JE, Deal BJ, Driscoll DJ, Estes NA 3rd, Araujo CG, Liang DH, Mitten MJ, Myerburg RJ, Pelliccia A, Thompson PD, Towbin JA, Van Camp SP; Working Groups of the American Heart Association |
|
Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery.
Circulation. 2004 Jun; 109(22):2755-60. Epub 2004 May 17
Bilgin YM, van de Watering LM, Eijsman L, Versteegh MI, Brand R, van Oers MH, Brand A. |
|
Fatality of future coronary events is related to inflammation-sensitive plasma proteins: a population-based prospective cohort study.
Circulation. 2004 Jun; 110(1):27-31. Epub 2004 Jun 21 2004 Jun 21
Engstrom G, Hedblad B, Stavenow L, Tyden P, Lind P, Janzon L, Lindgarde F. |
|
Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study.
Circulation. 2004 Jun; 110(1):74-8. Epub 2004 Jun 21
Matthews KA, Katholi CR, McCreath H, Whooley MA, Williams DR, Zhu S, Markovitz JH. |
|
Effect of aspirin and warfarin therapy in stroke patients with valvular strands.
Stroke. 2004 Jun; 35(6):1436-42. Epub 2004 Abr 8
Homma S, Di Tullio MR, Sciacca RR, Sacco RL, Mohr JP; PICSS Investigators |
|
Cigarette smoking and risk of stroke and its subtypes among middle-aged Japanese men and women: the JPHC StudyCohortI.
Stroke. 2004 Jun; 35(6):1248-53. Epub 2004 Abr 29
Mannami T, Iso H, Baba S, Sasaki S, Okada K, Konishi M, Tsugane S; Japan Public Health Center-Based Prospective Study on Cancer and Cardiovascular Disease Group. |
|
Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1.
Thromb Haemost. 2004 Jun; 91(6):1186-93.
Tanguay JF, Geoffroy P, Sirois MG, Libersan D, Kumar A, Schaub RG, Merhi Y |
|
Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.
Circulation. 2004 May; 109(19):2273-8. Epub 2004 May 3
Moussa I, Leon MB, Baim DS, O´Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, Kuntz RE, Moses JW. |
|
Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease.
Circulation. 2004 May; 109(18):2175-80. Epub 2004 Abr 26
Kiechl S, Schett G, Wenning G, Redlich K, Oberhollenzer M, Mayr A, Santer P, Smolen J, Poewe W, Willeit J |
|
Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.
Circulation. 2004 May; 109(18):2203-6. Epub 2004 Abr 26
Merlini PA, Rossi M, Menozzi A, Buratti S, Brennan DM, Moliterno DJ, Topol EJ, Ardissino D. |
|
Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not; The Hoorn Study.
Atherosclerosis. 2004 May; 174(1):49-56.
Henry RM, Ferreira I, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Kamp O, Bouter LM, Stehouwer CD. |
|
Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors.
Circulation. 2004 Abr; 109(16):1966-72. Epub 2004 Mar 29
Waehre T, Yndestad A, Smith C, Haug T, Tunheim SH, Gullestad L, Froland SS, Semb AG, Aukrust P, Damas JK |
